Zura Bio Ltd.

As of June 2, 2025, Zura Bio Ltd. shows a weak bearish sentiment, with mixed signals from indicators like the MACD, moving averages, and Bollinger Bands, indicating a transition from bearish to mildly bearish.

Zura Bio Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $17 million and a market cap of $70.54 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -41.58%.

As of Jun 18, Zura Bio Ltd. has a market capitalization of 70.54 million, with net sales of 0.00 million and a net profit of -62.10 million over the latest four quarters. As of Dec 24, shareholder's funds are at 146.81 million and total assets at 179.53 million.